Skip Navigation LinksHome > November 2013 - Volume 258 - Issue 5 > Liver Resection for Colorectal Metastases after Chemotherapy...
Annals of Surgery:
doi: 10.1097/SLA.0b013e3182a6183e
Original Articles From the ESA Proceedings

Liver Resection for Colorectal Metastases after Chemotherapy: Impact of Chemotherapy-Related Liver Injuries, Pathological Tumor Response, and Micrometastases on Long-term Survival

Viganò, Luca MD*; Capussotti, Lorenzo MD*; De Rosa, Giovanni MD; De Saussure, Wassila Oulhaci MD; Mentha, Gilles MD; Rubbia-Brandt, Laura MD§

Collapse Box

Abstract

Objectives: We analyzed the impact of chemotherapy-related liver injuries (CALI), pathological tumor regression grade (TRG), and micrometastases on long-term prognosis in patients undergoing liver resection for colorectal metastases after preoperative chemotherapy.

Background: CALI worsen the short-term outcomes of liver resection, but their impact on long-term prognosis is unknown. Recently, a prognostic role of TRG has been suggested. Micrometastases (microscopic vascular or biliary invasion) are reduced by preoperative chemotherapy, but their impact on survival is unclear.

Methods: Patients undergoing liver resection for colorectal metastases between 1998 and 2011 and treated with oxaliplatin and/or irinotecan-based preoperative chemotherapy were eligible for the study. Patients with operative mortality or incomplete resection (R2) were excluded. All specimens were reviewed to assess CALI, TRG, and micrometastases.

Results: A total of 323 patients were included. Grade 2–3 sinusoidal obstruction syndrome (SOS) was present in 124 patients (38.4%), grade 2–3 steatosis in 73 (22.6%), and steatohepatitis in 30 (9.3%). Among all patients, 22.9% had TRG 1–2 (major response), whereas 55.7% had TRG 4–5 (no response). Microvascular invasion was detected in 37.8% of patients and microscopic biliary infiltration in 5.6%.

The higher the SOS grade the lower the pathological response: TRG 1–2 occurred in 16.9% of patients with grade 2–3 SOS versus 26.6% of patients with grade 0–1 SOS (P = 0.032).

After a median follow-up of 36.9 months, 5-year survival was 38.6%. CALI did not negatively impact survival. Multivariate analysis showed that grade 2–3 steatosis was associated with better survival than grade 0–1 steatosis (5-year survival rate of 52.5% vs 35.2%, P = 0.002). TRG better than the percentage of viable cells stratified patient prognosis: 5-year survival rate of 60.4% in TRG 1–2, 40.2% in TRG 3, and 29.8% in TRG 4–5 (P = 0.0001). Microscopic vascular and biliary invasion negatively impacted outcome (5-year survival rate of 23.3% vs 45.7% if absent, P = 0.017; 0% vs 42.3%, P = 0.032, respectively).

Conclusions: TRG was confirmed to be a crucial prognostic determinant. CALI do not negatively impact long-term prognosis, but the tumor response is reduced in patients with grade 2–3 SOS. Steatosis was found to have a protective effect on survival. Micrometastases significantly impacted prognosis assessment.

© 2013 by Lippincott Williams & Wilkins.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.